Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Long-term complete response to very-low-dose interleukin-2 therapy in patients ... - UroToday |
 |
 |
|
UroToday Before the advent of molecular-targeted agents, immunotherapy using cytokines, such as interferon-? (IFN-?) and interleukin-2 (IL-2), had been the mainstay of treatment for patients with metastatic renal cell carcinoma (mRCC), and this therapy may |
